newsfilter
← Latest News
Business Wire·

Cerevance Appoints Clinical Development Veteran Dr. Aoife Brennan to Board of Directors

BOSTON--(BUSINESS WIRE)--Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, today announced the appointment of Aoife Brennan, M.B., B.Ch., to its board of directors effective January 1, 2020.